会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明专利
    • BR0114763A
    • 2004-04-20
    • BR0114763
    • 2001-10-12
    • ORTHO MCNEIL PHARM INCKOSAN BIOSCIENCES INC
    • HLASTA DENNISHENNINGER TODD CGRANT EUGENE BKHOSLA CHAITINCHU DANIEL T WASHLEY GARY
    • A61K31/7048A61P31/04C07H17/08
    • The present invention includes compounds of the formulawherein:X is hydrogen or halide;R2 is hydrogen, acyl, or a hydroxy protecting group;R6 is hydrogen, hydroxyl, or -ORa wherein Ra is a substituted or unsubstituted moiety selected from the group consisting of C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl, heterocyclo, aryl(C1-C10)alkyl, aryl(C2-C10)alkenyl, aryl(C2-C10)alkynyl, heterocyclo(C1-C10)alkyl, heterocyclo(C2-C10)alkenyl, and heterocyclo(C2-C10)alkynyl;R13 is hydrogen or a substituted or unsubstituted moiety wherein the moiety is selected from the group consisting of methyl; C3-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl, heterocyclo, aryl(C1-C10)alkyl, aryl(C2-C10)alkenyl, aryl(C2-C10)alkynyl, heterocyclo(C1-C10)alkyl, heterocyclo(C2-C10)alkenyl, and heterocyclo(C2-C10)alkynyl; and,R is hydrogen or a substituted or unsubstituted moiety wherein the moiety is selected from the group consisting of C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl, heterocyclo, aryl(C1-C10)alkyl, aryl(C2-C10)alkenyl, aryl(C2-C10)alkynyl, heterocyclo(C1-C10)alkyl, heterocyclo(C2-C10)alkenyl, and heterocyclo(C2-C10)alkynyl;and the pharmaceutically acceptable salts, esters and pro-drug forms thereof. These compounds possess anti-infective activity and are useful for the treatment of bacterial and protozoal infections.
    • 4. 发明专利
    • KETOLIDE ANTIBACTERIAL COMPOUNDS
    • HU0303935A2
    • 2004-06-28
    • HU0303935
    • 2001-10-12
    • KOSAN BIOSCIENCES INCORTHO MCNEIL PHARM INC
    • ASHLEY GARYCHU DANIEL T WGRANT EUGENE BHENNINGER TODD CHLASTA DENNISKHOSLA CHAITIN
    • A61K31/7048A61P31/04C07H17/08
    • The present invention includes compounds of the formulawherein:X is hydrogen or halide;R2 is hydrogen, acyl, or a hydroxy protecting group;R6 is hydrogen, hydroxyl, or -ORa wherein Ra is a substituted or unsubstituted moiety selected from the group consisting of C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl, heterocyclo, aryl(C1-C10)alkyl, aryl(C2-C10)alkenyl, aryl(C2-C10)alkynyl, heterocyclo(C1-C10)alkyl, heterocyclo(C2-C10)alkenyl, and heterocyclo(C2-C10)alkynyl;R13 is hydrogen or a substituted or unsubstituted moiety wherein the moiety is selected from the group consisting of methyl; C3-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl, heterocyclo, aryl(C1-C10)alkyl, aryl(C2-C10)alkenyl, aryl(C2-C10)alkynyl, heterocyclo(C1-C10)alkyl, heterocyclo(C2-C10)alkenyl, and heterocyclo(C2-C10)alkynyl; and,R is hydrogen or a substituted or unsubstituted moiety wherein the moiety is selected from the group consisting of C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl, heterocyclo, aryl(C1-C10)alkyl, aryl(C2-C10)alkenyl, aryl(C2-C10)alkynyl, heterocyclo(C1-C10)alkyl, heterocyclo(C2-C10)alkenyl, and heterocyclo(C2-C10)alkynyl;and the pharmaceutically acceptable salts, esters and pro-drug forms thereof. These compounds possess anti-infective activity and are useful for the treatment of bacterial and protozoal infections.
    • 5. 发明专利
    • KETOLIDE ANTIBACTERIALS
    • CA2426593A1
    • 2002-04-25
    • CA2426593
    • 2001-10-12
    • ORTHO MCNEIL PHARM INCKOSAN BIOSCIENCES INC
    • HLASTA DENNISKHOSLA CHAITINGRANT EUGENE BHENNINGER TODD CASHLEY GARYCHU DANIEL T W
    • A61K31/7048A61P31/04C07H17/08
    • The present invention includes compounds of the formula wherein: X is hydrog en or halide; R2 is hydrogen, acyl, or a hydroxy protecting group; R6 is hydrogen, hydroxyl, or -ORa wherein Ra is a substituted or unsubstituted moiety selected from the group consisting of C1-C10 alkyl, C2-C10 alkenyl, C 2- C10 alkynyl, aryl, heterocyclo, aryl(C1-C10)alkyl, aryl(C2-C10)alkenyl, aryl(C2-C10)alkynyl, heterocyclo(C1-C10)alkyl, heterocyclo(C2-C10)alkenyl, a nd heterocyclo(C2-C10)alkynyl; R13 is hydrogen or a substituted or unsubstitute d moiety wherein the moiety is selected from the group consisting of methyl; C 3- C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl, heterocyclo, aryl(C1- C10)alkyl, aryl(C2-C10)alkenyl, aryl(C2-C10)alkynyl, heterocyclo(C1-C10)alky l, heterocyclo(C2-C10)alkenyl, and heterocyclo(C2-C10)alkynyl;and, R is hydroge n or a substituted or unsubstituted moiety wherein the moiety is selected from the group consisting of C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl, heterocyclo, aryl(C1-C10)alkyl, aryl(C2-C10)alkenyl, aryl(C2-C10)alkynyl, heterocyclo(C1-C10)alkyl, heterocyclo(C2-C10)alkenyl, and heterocyclo(C2- C10)alkynyl;and the pharmaceutically acceptable salts, esters and pro-drug forms thereof. These compounds possess anti-infective activity and are usefu l for the treatment of bacterial and protozoal infections.
    • 7. 发明专利
    • KETOLIDE ANTIBACTERIALS
    • PL362005A1
    • 2004-10-18
    • PL36200501
    • 2001-10-12
    • ORTHO MCNEIL PHARM INCKOSAN BIOSCIENCES INC
    • HLASTA DENNISHENNINGER TODD CGRANT EUGENE BKHOSLA CHAITINCHU DANIEL T WASHLEY GARY
    • A61K31/7048A61P31/04C07H17/08
    • The present invention includes compounds of the formulawherein:X is hydrogen or halide;R2 is hydrogen, acyl, or a hydroxy protecting group;R6 is hydrogen, hydroxyl, or -ORa wherein Ra is a substituted or unsubstituted moiety selected from the group consisting of C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl, heterocyclo, aryl(C1-C10)alkyl, aryl(C2-C10)alkenyl, aryl(C2-C10)alkynyl, heterocyclo(C1-C10)alkyl, heterocyclo(C2-C10)alkenyl, and heterocyclo(C2-C10)alkynyl;R13 is hydrogen or a substituted or unsubstituted moiety wherein the moiety is selected from the group consisting of methyl; C3-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl, heterocyclo, aryl(C1-C10)alkyl, aryl(C2-C10)alkenyl, aryl(C2-C10)alkynyl, heterocyclo(C1-C10)alkyl, heterocyclo(C2-C10)alkenyl, and heterocyclo(C2-C10)alkynyl; and,R is hydrogen or a substituted or unsubstituted moiety wherein the moiety is selected from the group consisting of C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl, heterocyclo, aryl(C1-C10)alkyl, aryl(C2-C10)alkenyl, aryl(C2-C10)alkynyl, heterocyclo(C1-C10)alkyl, heterocyclo(C2-C10)alkenyl, and heterocyclo(C2-C10)alkynyl;and the pharmaceutically acceptable salts, esters and pro-drug forms thereof. These compounds possess anti-infective activity and are useful for the treatment of bacterial and protozoal infections.
    • 8. 发明专利
    • Ketolide antibacterial formulations
    • CZ20031095A3
    • 2004-06-16
    • CZ20031095
    • 2001-10-12
    • ORTHO MCNEIL PHARM INCKOSAN BIOSCIENCES INC
    • HLASTA DENISHENNINGER TODD CGRANT EUGENE BKHOSLA CHAITINCHU DANIEL T WASHLEY GARY
    • A61K31/7048A61P31/04C07H17/08
    • The present invention includes compounds of the formulawherein:X is hydrogen or halide;R2 is hydrogen, acyl, or a hydroxy protecting group;R6 is hydrogen, hydroxyl, or -ORa wherein Ra is a substituted or unsubstituted moiety selected from the group consisting of C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl, heterocyclo, aryl(C1-C10)alkyl, aryl(C2-C10)alkenyl, aryl(C2-C10)alkynyl, heterocyclo(C1-C10)alkyl, heterocyclo(C2-C10)alkenyl, and heterocyclo(C2-C10)alkynyl;R13 is hydrogen or a substituted or unsubstituted moiety wherein the moiety is selected from the group consisting of methyl; C3-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl, heterocyclo, aryl(C1-C10)alkyl, aryl(C2-C10)alkenyl, aryl(C2-C10)alkynyl, heterocyclo(C1-C10)alkyl, heterocyclo(C2-C10)alkenyl, and heterocyclo(C2-C10)alkynyl; and,R is hydrogen or a substituted or unsubstituted moiety wherein the moiety is selected from the group consisting of C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl, heterocyclo, aryl(C1-C10)alkyl, aryl(C2-C10)alkenyl, aryl(C2-C10)alkynyl, heterocyclo(C1-C10)alkyl, heterocyclo(C2-C10)alkenyl, and heterocyclo(C2-C10)alkynyl;and the pharmaceutically acceptable salts, esters and pro-drug forms thereof. These compounds possess anti-infective activity and are useful for the treatment of bacterial and protozoal infections.
    • 9. 发明专利
    • Ketolide antibacterials.
    • ZA200303795B
    • 2004-05-17
    • ZA200303795
    • 2003-05-15
    • ORTHO MCNEIL PHARM INCKOSAN BIOSCIENCES INC
    • HLASTA DENNISGRANT EUGENE BCHU DANIEL T WHENNINGER TODD CKHOSLA CHAITINASHLEY GARY
    • A61K31/7048A61P31/04C07H17/08C07HA61KA61P
    • The present invention includes compounds of the formulawherein:X is hydrogen or halide;R2 is hydrogen, acyl, or a hydroxy protecting group;R6 is hydrogen, hydroxyl, or -ORa wherein Ra is a substituted or unsubstituted moiety selected from the group consisting of C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl, heterocyclo, aryl(C1-C10)alkyl, aryl(C2-C10)alkenyl, aryl(C2-C10)alkynyl, heterocyclo(C1-C10)alkyl, heterocyclo(C2-C10)alkenyl, and heterocyclo(C2-C10)alkynyl;R13 is hydrogen or a substituted or unsubstituted moiety wherein the moiety is selected from the group consisting of methyl; C3-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl, heterocyclo, aryl(C1-C10)alkyl, aryl(C2-C10)alkenyl, aryl(C2-C10)alkynyl, heterocyclo(C1-C10)alkyl, heterocyclo(C2-C10)alkenyl, and heterocyclo(C2-C10)alkynyl; and,R is hydrogen or a substituted or unsubstituted moiety wherein the moiety is selected from the group consisting of C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl, heterocyclo, aryl(C1-C10)alkyl, aryl(C2-C10)alkenyl, aryl(C2-C10)alkynyl, heterocyclo(C1-C10)alkyl, heterocyclo(C2-C10)alkenyl, and heterocyclo(C2-C10)alkynyl;and the pharmaceutically acceptable salts, esters and pro-drug forms thereof. These compounds possess anti-infective activity and are useful for the treatment of bacterial and protozoal infections.
    • 10. 发明申请
    • KETOLIDE ANTIBACTERIALS
    • 卡介胶抗菌素
    • WO0232918A3
    • 2003-01-03
    • PCT/US0132119
    • 2001-10-12
    • ORTHO MCNEIL PHARM INC
    • HLASTA DENNISHENNINGER TODD CGRANT EUGENE BKHOSLA CHAITINCHU DANIEL T WASHLEY GARY
    • A61K31/7048A61P31/04C07H17/08
    • C07H17/08Y02P20/55
    • The present invention includes compounds of the formula wherein: X is hydrogen or halide; R is hydrogen, acyl, or a hydroxy protecting group; R is hydrogen, hydroxyl, or -OR wherein R is a substituted or unsubstituted moiety selected from the group consisting of C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl, heterocyclo, aryl(C1-C10)alkyl, aryl(C2-C10)alkenyl, aryl(C2-C10)alkynyl, heterocyclo(C1-C10)alkyl, heterocyclo(C2-C10)alkenyl, and heterocyclo(C2-C10)alkynyl; R is hydrogen or a substituted or unsubstituted moiety wherein the moiety is selected from the group consisting of methyl; C3-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl, heterocyclo, aryl(C1-C10)alkyl, aryl(C2-C10)alkenyl, aryl(C2-C10)alkynyl, heterocyclo(C1-C10)alkyl, heterocyclo(C2-C10)alkenyl, and heterocyclo(C2-C10)alkynyl;and, R is hydrogen or a substituted or unsubstituted moiety wherein the moiety is selected from the group consisting of C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl, heterocyclo, aryl(C1-C10)alkyl, aryl(C2-C10)alkenyl, aryl(C2-C10)alkynyl, heterocyclo(C1-C10)alkyl, heterocyclo(C2-C10)alkenyl, and heterocyclo(C2-C10)alkynyl;and the pharmaceutically acceptable salts, esters and pro-drug forms thereof. These compounds possess anti-infective activity and are useful for the treatment of bacterial and protozoal infections.
    • 本发明包括下式的化合物其中:X是氢或卤化物; R 2是氢,酰基或羟基保护基; R 6是氢,羟基或-OR a,其中R a是选自C1-C10烷基,C2-C10烯基,C2-C10炔基,芳基,杂环的取代或未取代的部分 ,芳基(C 1 -C 10)烷基,芳基(C 2 -C 10)烯基,芳基(C 2 -C 10)炔基,杂环(C 1 -C 10)烷基,杂环(C 2 -C 10)烯基和杂环(C 2 -C 10) R 13是氢或取代或未取代的部分,其中部分选自甲基; C 1 -C 10烷基,C 2 -C 10烯基,C 2 -C 10炔基,芳基,杂环基,芳基(C 1 -C 10)烷基,芳基(C 2 -C 10) ,杂环基(C 2 -C 10)烯基和杂环基(C 2 -C 10)炔基;且R是氢或取代或未取代的部分,其中该部分选自C1-C10烷基,C2-C10链烯基,C2 -C 1 -C 10炔基,芳基,杂环基,芳基(C 1 -C 10)烷基,芳基(C 2 -C 10)烯基,芳基(C 2 -C 10)炔基,杂环(C 1 -C 10)烷基,杂环(C 2 -C 10) (C 2 -C 10)炔基;及其药学上可接受的盐,酯和前药形式。 这些化合物具有抗感染活性,可用于治疗细菌和原生动物感染。